Suradej Hongeng
Overview
Explore the profile of Suradej Hongeng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
269
Citations
2715
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Namporn T, Manopwisedjaroen S, Ngodngamthaweesuk M, Pasomsub E, Jiravejchakul N, Saengfak R, et al.
Emerg Microbes Infect
. 2025 Mar;
:2477845.
PMID: 40059759
Monkeypox virus (Mpox) has been recognized for causing distinct skin lesions and is primarily transmitted through skin and sexual contact. To date, the transmissibility and pathogenesis of the Mpox virus...
2.
Thiraporn A, Tiyasakulchai T, Khamkhenshorngphanuch T, Hoarau M, Thiabma R, Onnome S, et al.
ACS Bio Med Chem Au
. 2025 Feb;
5(1):89-105.
PMID: 39990944
In our study, Prodrug nucleoTide (ProTide) technology was applied to cordycepin to enhance its antiviral activities and metabolic stability. Using cordycepin as starting material, we developed a synthetic method to...
3.
Kongsomros S, Boonyarattanasoonthorn T, Phongphaew W, Kasorndorkbua C, Sunyakumthorn P, Im-Erbsin R, et al.
J Tradit Complement Med
. 2025 Jan;
14(6):598-610.
PMID: 39850600
The ongoing COVID-19 pandemic has triggered extensive research, mainly focused on identifying effective therapeutic agents, specifically those targeting highly pathogenic SARS-CoV-2 variants. This study aimed to investigate the antiviral efficacy...
4.
Iida M, Ho A, Huang X, Liu K, Lv M, Huang H, et al.
Blood Cell Ther
. 2024 Dec;
7(4):129-137.
PMID: 39651061
COVID-19 became a global pandemic in 2020 and significantly affected the activity of hematopoietic cell transplants (HCT) worldwide. Despite these challenges, a total of 28,793 transplants, including 18,518 allogeneic and...
5.
Chaopreecha J, Phueakphud N, Suksatu A, Krobthong S, Manopwisedjaroen S, Panyain N, et al.
Phytomedicine
. 2024 Dec;
136():156279.
PMID: 39631298
Background: Andrographolide is a medicinal compound which possesses anti-SARS-CoV-2 activity. A number of cellular targets of andrographolide have been identified by target predictions and computational studies. Purpose: However, a potential...
6.
Kwiatkowski J, Walters M, Hongeng S, Yannaki E, Kulozik A, Kunz J, et al.
Lancet
. 2024 Nov;
404(10468):2175-2186.
PMID: 39527960
Background: Transfusion-dependent β-thalassaemia (TDT) is a severe disease, resulting in lifelong blood transfusions, iron overload, and associated complications. Betibeglogene autotemcel (beti-cel) gene therapy uses autologous haematopoietic stem and progenitor cells...
7.
Kanjanasirirat P, Saengsawang W, Ketsawatsomkron P, Asavapanumas N, Borwornpinyo S, Soodvilai S, et al.
Heliyon
. 2024 Nov;
10(20):e39343.
PMID: 39492921
Blood-brain barrier (BBB) is a crucial membrane safeguarding neural tissue by controlling the molecular exchange between blood and the brain. However, assessing BBB permeability presents challenges for central nervous system...
8.
Janpipatkul K, Sutjarit N, Tangprasittipap A, Chaiamarit T, Innachai P, Suksen K, et al.
Orphanet J Rare Dis
. 2024 Oct;
19(1):363.
PMID: 39358794
Background: Gaucher disease (GD) is one of the most common types of lysosomal storage diseases (LSDs) caused by pathogenic variants of lysosomal β-glucocerebrosidase gene (GBA1), resulting in the impairment of...
9.
Nokchan N, Suthapot P, Choochuen P, Khongcharoen N, Hongeng S, Anurathapan U, et al.
J Pers Med
. 2024 Sep;
14(9).
PMID: 39338204
Neuroblastoma is the most prevalent solid tumor in early childhood, with a 5-year overall survival rate of 40-60% in high-risk cases. Therefore, the identification of novel biomarkers for the diagnosis,...
10.
Suwantarat N, Iamsirirak P, Chanapai J, Pakakasama S, Andersson B, Boelens J, et al.
Pediatr Blood Cancer
. 2024 Sep;
71(11):e31311.
PMID: 39228048
No abstract available.